1. |
Pouly JL, Canis M, Velemir L. Endometriosis related infertility. J Gynecol Obstet Biol Reprod, 2007, 36(2):151-161.
|
2. |
Vercellini P, Somigliana E, Viganò P, et al. Surgery for endometriosis-associated infertility:a pragmatic approach. Hum Reprod, 2009, 24(2):254-269.
|
3. |
Abu Hashim H. Gonadotrophin-releasing hormone analogues and endometriosis:current strategies and new insights. Gynecological Endocrinol, 2012, 8(4):314-321.
|
4. |
The American Fertility Society. Revised American Fertility Society classification of endometriosis:1985. Fertil Steril, 1985, 43(3):351-352.
|
5. |
Biberoglu KO, Behrman SJ. Dosage aspects of danazol therapy in endometriosis:short-term and long-term effectiveness. Am J Obstet Gynecol, 1981, 139(6):645-654.
|
6. |
Bergqvist A, Bergh T, Hogström L, et al. Effects of triptorelin versus placebo on the symptoms of endometriosis. Fertil Steril, 1998, 69(4):702-708.
|
7. |
Rickes D, Nickel I, Kropf S, et al. Increased pregnancy rates after ultralong postoperative therapy with gonadotropinreleasing hormone analogs in patients with endometriosis. Fertil Steril, 2002, 78(4):757-762.
|
8. |
Cochrane Handbook for Systematic Reviews of Interventions. Accessed at http://handbook.cochrane.org/on1February2013.
|
9. |
秦海霞, 陈友国, 沈宗姬, 等.腹腔镜手术联合GnRH-a类药物治疗子宫内膜异位症伴不孕的疗效观察.医学信息手术学分册, 2007, 20(10):867-869.
|
10. |
苏丽, 岳瑛, 何凯. GnRH-a用于子宫内膜异位症术后的疗效观察.中国伤残医学, 2008, 16(5):54-55.
|
11. |
唐淼, 陈华莲.曲普瑞林在卵巢子宫内膜异位囊肿腹腔镜术后的疗效观察.安徽医药, 2010, 14(10):1215-1216.
|
12. |
关菁, 沈浣, 刘亚南, 等.腹腔镜术后应用促性腺激素释放激素激动剂对I期子宫内膜异位症不孕患者生育能力的影响.中华妇产科杂志, 2010, 45(4):264-268.
|
13. |
姚翠红, 腹腔镜联合药物治疗子宫内膜异位症的效果观察.临床医学, 2010, 23(1):64.
|
14. |
陈旭萍, 手术联合药物治疗子宫内膜异位症89例观察.中国基层医药, 2011, 18(15):2100-2101.
|
15. |
顾汉平, 孟丽.腹腔镜手术联合达菲林治疗子宫内膜异位症伴不孕症的疗效.实用临床医学, 2012, 13(10):79-80.
|
16. |
何家纯, 杨艳明, 陈卓, 等.腹腔镜术后辅助GnRH治疗子宫内膜异位症的临床观察.医学信息, 2012, 25(1):137-138.
|
17. |
金筱筱.腹腔镜手术联合GnRH激动剂治疗子宫内膜异位症的临床分析.海峡药学, 2012, 24(9):166-167.
|
18. |
刘艳红, 陆晓媛.保守手术联合药物治疗Ⅲ-Ⅳ期子宫内膜异位症的临床疗效分析.吉林医学, 2013, 34(3):442-443.
|
19. |
Parazzini F, Fedele L, Busacca M, et al. Gynecology:Postsurgical Medical Treatment of Advanced Endometriosis:Results of a Randomized Clinical Trial. Am J Obstet Gynecol, 1994, 171(5):1205-1207.
|
20. |
Hornatein MD, Hemmings R, Yuzpe AA. Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis. Fertil Steril, 1997, 68(5):860-864.
|
21. |
Vercellini P, Crosignani PG, Fadini R, et al. A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol, 1999, 106(7):672-677.
|
22. |
Busacca M, Somigliana E, Bianchi S, et al. Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage Ⅲ-Ⅳ:a randomized controlled trial. Hum Reprod, 2001, 16(11):2399-2402.
|
23. |
Loverro G, Carriero C, Rossi AC, et al. A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage Ⅲ-Ⅳ endometriosis. Eur J Obstet Gynecol Reprod Biol, 2008, 136(2):194-198.
|
24. |
de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility:pathophysiology and management. Lancet, 2010, 3769(9742):730-738.
|
25. |
Hart RJ, Hickey M, Maouris P, et al. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev, 2011:CD004992.
|
26. |
Furness S, Ya C, Farquha C, et al. Pre and post operative medical therapy for endometriosis surgery. Cochrane Database Syst Rev, 2010:CD003678.
|
27. |
Sesti F, Pietropolli A, Capozzolo T, et al. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage Ⅲ-Ⅳ. A randomized comparative trial. Fertil Steril, 2007, 88(6):1541-1547.
|